Cargando…
Effects of cabergoline on blood glucose levels in type 2 diabetic patients: A double-blind controlled clinical trial
BACKGROUND: Cabergoline is a long-acting agonist of dopamine, which has a high affinity to dopamine receptors (type 2). Treatment using a dopaminergic agonist reduces hypothalamic stimulation that increases during liver gluconeogenesis, lipids synthesis, and insulin resistance. Our aim was to evalua...
Autores principales: | Bahar, Adele, Kashi, Zahra, Daneshpour, Ezzatossadat, Akha, Ozra, Ala, Shahram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059036/ https://www.ncbi.nlm.nih.gov/pubmed/27749534 http://dx.doi.org/10.1097/MD.0000000000004818 |
Ejemplares similares
-
Effects of a hydroalcoholic extract of Juglans regia (walnut) leaves on blood glucose and major cardiovascular risk factors in type 2 diabetic patients: a double-blind, placebo-controlled clinical trial
por: Rabiei, Khadijeh, et al.
Publicado: (2018) -
Dose administration time from before breakfast to before dinner affect thyroid hormone levels?
por: Ala, Shahram, et al.
Publicado: (2015) -
Levothyroxine Dosage Requirement During Pregnancy in Well-Controlled Hypothyroid Women: A Longitudinal Study
por: Kashi, Zahra, et al.
Publicado: (2016) -
The ratio of estimated average glucose to fasting plasma glucose level as an indicator of insulin resistance in young adult diabetes: An observational study
por: Guo, Jun, et al.
Publicado: (2020) -
Effect of the nurse-led program on blood glucose control and microalbuminuria development in type 2 diabetic populations
por: Li, Ling, et al.
Publicado: (2022)